

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
You can purchase shares of PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (OTCEM:PBLA) through any online brokerage.
There are no as such competitors for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..
PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. has a consensus price target of $25.00.
The stock price for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. (OTCEM: PBLA) is $0.0111 last updated October 26, 2026 at 1:15 PM EDT.
There are no upcoming dividends for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..
PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc..
PANBELA THERAPEUTICS INC by Panbela Therapeutics, Inc. is in the Health Care sector and Biotechnology industry. They are listed on the OTCEM.
Panbela Therapeutics Inc is a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs. The Company's pipeline assets are ivospemin (SBP-101), FlynpoviTM (eflornithine...